Share:

Daniel Couto

COO of Vedanta Bio

Preparing for Series D Funding: Daniel Couto, COO at Vedanta Bio

Daniel Couto is the COO of Vedanta Biosciences, a leading microbiome company who recently completed $68 Million Series D Financing. Dan has nearly 30 years of experience starting and advancing biopharmaceutical development and manufacturing organizations to higher levels of capability, growth and productivity.

Vedanta is developing a novel class of therapies that modulate pathways of interaction between the human microbiome and the host immune system.

Let's talk

Get in touch with one of our
specialist consultants today.

Stay connected